scholarly journals A Genome-Wide Profiling of the Humoral Immune Response toChlamydia trachomatisInfection Reveals Vaccine Candidate Antigens Expressed in Humans

2010 ◽  
Vol 185 (3) ◽  
pp. 1670-1680 ◽  
Author(s):  
Jie Wang ◽  
Yingqian Zhang ◽  
Chunxue Lu ◽  
Lei Lei ◽  
Ping Yu ◽  
...  
Keyword(s):  
Immune Response ◽  
Humoral Immune Response ◽  
Vaccine Candidate ◽  
Humoral Immune ◽  
Genome Wide ◽  
A Genome

scholarly journals Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections

2021 ◽  
Vol 12 ◽  
Author(s):  
Byoung-Jun Kim ◽  
Hyein Jeong ◽  
Hyejun Seo ◽  
Mi-Hyun Lee ◽  
Hyun Mu Shin ◽  
...  
Keyword(s):  
Immune Response ◽  
Single Dose ◽  
Immune Responses ◽  
Receptor Binding ◽  
Humoral Immune Response ◽  
Vaccine Candidate ◽  
Binding Domain ◽  
Receptor Binding Domain ◽  
Live Virus ◽  
Humoral Immune

At present, concerns that the recent global emergence of SARS-CoV-2 variants could compromise the current vaccines have been raised, highlighting the urgent demand for new vaccines capable of eliciting T cell-mediated immune responses, as well as B cell-mediated neutralizing antibody production. In this study, we developed a novel recombinant Mycobacterium paragordonae expressing the SARS-CoV-2 receptor-binding domain (RBD) (rMpg-RBD-7) that is capable of eliciting RBD-specific immune responses in vaccinated mice. The potential use of rMpg-RBD-7 as a vaccine for SARS-CoV-2 infections was evaluated in in vivo using mouse models of two different modules, one for single-dose vaccination and the other for two-dose vaccination. In a single-dose vaccination model, we found that rMpg-RBD-7 versus a heat-killed strain could exert an enhanced cell-mediated immune (CMI) response, as well as a humoral immune response capable of neutralizing the RBD and ACE2 interaction. In a two-dose vaccination model, rMpg-RBD-7 in a two-dose vaccination could also exert a stronger CMI and humoral immune response to neutralize SARS-CoV-2 infections in pseudoviral or live virus infection systems, compared to single dose vaccinations of rMpg-RBD or two-dose RBD protein immunization. In conclusion, our data showed that rMpg-RBD-7 can lead to an enhanced CMI response and humoral immune responses in mice vaccinated with both single- or two-dose vaccination, highlighting its feasibility as a novel vaccine candidate for SARS-CoV-2. To the best of our knowledge, this study is the first in which mycobacteria is used as a delivery system for a SARS-CoV-2 vaccine.

scholarly journals Comparison of gE/gI- and TK/gE/gI-Gene-Deleted Pseudorabies Virus Vaccines Mediated by CRISPR/Cas9 and Cre/Lox Systems

Viruses ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 369
Author(s):  
Jianglong Li ◽  
Kui Fang ◽  
Zhenxiang Rong ◽  
Xinxin Li ◽  
Xujiao Ren ◽  
...  
Keyword(s):  
Immune Response ◽  
Cd8 T Cells ◽  
Humoral Immune Response ◽  
Pseudorabies Virus ◽  
Vaccine Candidate ◽  
Clinical Signs ◽  
Humoral Immune ◽  
Viral Shedding ◽  
Ifn Γ ◽  
Efficacious Vaccine

Pseudorabies (PR), caused by pseudorabies virus (PRV), is an acute and febrile infectious disease in swine. To eradicate PR, a more efficacious vaccine needs to be developed. Here, the gE/gI- and TK/gE/gI-gene-deleted recombinant PRV (rGXΔgE/gI and rGXΔTK/gE/gI) are constructed through CRISPR/Cas9 and Cre/Lox systems. We found that the rGXΔTK/gE/gI was safer than rGXΔgE/gI in mice. Additionally, the effects of rGXΔgE/gI and rGXΔTK/gE/gI were further evaluated in swine. The rGXΔgE/gI and rGXΔTK/gE/gI significantly increased numbers of IFN-γ-producing CD4+ and CD8+ T-cells in swine, whereas there was no difference between rGXΔgE/gI and rGXΔTK/gE/gI. Moreover, rGXΔgE/gI and rGXΔTK/gE/gI promoted a PRV-specific humoral immune response. The PRV-specific humoral immune response induced by rGXΔgE/gI was consistent with that caused by rGXΔTK/gE/gI. After the challenge, swine vaccinated with rGXΔgE/gI and rGXΔTK/gE/gI showed no clinical signs and viral shedding. However, histopathological detection revealed that rGXΔgE/gI, not rGXΔTK/gE/gI, caused pathological lesions in brain and lung tissues. In summary, these results demonstrate that the TK/gE/gI-gene-deleted recombinant PRV was safer compared with rGXΔgE/gI in swine. The data imply that the TK/gE/gI-gene-deleted recombinant PRV may be a more efficacious vaccine candidate for the prevention of PR.

scholarly journals Assessment of humoral immune response of a Cytomegalovirus DNA-vaccine candidate in BALB/c mice

2015 ◽  
Vol 2 (3) ◽  
pp. 33-37
Author(s):  
R Vahabpour ◽  
MR Aghasadeghi ◽  
F Goudarzifar ◽  
H Keyvani ◽  
A Ataei- Pirkooh ◽  
...  
Keyword(s):  
Immune Response ◽  
Dna Vaccine ◽  
Humoral Immune Response ◽  
Vaccine Candidate ◽  
Humoral Immune

scholarly journals Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray

PROTEOMICS ◽  
2010 ◽  
Vol 10 (12) ◽  
pp. 2259-2269 ◽  
Author(s):  
Adam Vigil ◽  
Rocio Ortega ◽  
Rie Nakajima-Sasaki ◽  
Jozelyn Pablo ◽  
Douglas M. Molina ◽  
...  
Keyword(s):  
Immune Response ◽  
Coxiella Burnetii ◽  
Humoral Immune Response ◽  
Protein Microarray ◽  
Humoral Immune ◽  
Genome Wide

Role of Yersinia pseudotuberculosis outer proteins (Yops) in murine humoral immune response

2009 ◽  
Vol 54 (3) ◽  
pp. 239-245 ◽  
Author(s):  
J. M. L. Maia ◽  
L. G. S. Monnazzi ◽  
B. M. M. Medeiros
Keyword(s):  
Immune Response ◽  
Humoral Immune Response ◽  
Yersinia Pseudotuberculosis ◽  
Humoral Immune

scholarly journals Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune response

2021 ◽  
pp. 113043
Author(s):  
Marnix Mylemans ◽  
Eveline Van Honacker ◽  
Louis Nevejan ◽  
Stefanie van den Bremt ◽  
Laura Hofman ◽  
...  
Keyword(s):  
Immune Response ◽  
Performance Evaluation ◽  
Humoral Immune Response ◽  
Analytical Performance ◽  
Humoral Immune
Sign in / Sign up

Export Citation Format

Share Document